Both in Pharmaceuticals
GT Biopharma vs Theriva Biologics
Over the past year GTBP returned −66.9% and TOVX returned −42.7%; their daily moves had a correlation of 0.06.
GTBP −66.9% TOVX −42.7%Growth of $1, one year, split-adjusted
| Metric | GTBP | TOVX |
|---|---|---|
| Price | $5.51 | $0.1899 |
| Market cap | $9.9M | $8.7M |
| Today | −1.25% | +1.01% |
| 1 month | −19.9% | −9.6% |
| 6 months | −19.0% | −42.5% |
| Year to date | −71.9% | −9.7% |
| 1 year | −68.3% | −42.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 29.1× |
| Net cash | $5.0M | $9.7M |
| Dividend yield | — | — |
| Volatility (60d) | 958.3% | 45.9% |
| Short % of float | 24.1% | 4.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).